Sadeer G. Al-Kindi

TL;DR: This review provides an overview of air pollution and health, including assessment of exposure, impact on CV outcomes, mechanistic underpinnings, and impact ofAir pollution reduction strategies to mitigate CV risk, and concludes with future challenges.

TL;DR: The empirical evidence supporting the effects of air pollution on cardiovascular health is examined, potential mechanisms that lead to increased cardiovascular risk are described, and measures to reduce this risk and identify key gaps in knowledge that could help address the increasing cardiovascular morbidity and mortality associated with air pollution are discussed.

TL;DR: An exhortation for formal inclusion of air pollution as a major risk factor in societal guidelines and provision of formal recommendations to prevent adverse cardiovascular effects attributable to air pollution is exhorted.

TL;DR: In the largest US-based retrospective study, the addition of Impella to VA-ECMO for patients with refractory cardiogenic shock was associated with lower all-cause 30 day mortality, lower inotrope use, and comparable safety profiles as compared with VA- ECMO alone.

TL;DR: The prevalence of CVDs is unexpectedly high and suboptimally managed in patients with cancer and coexisting heart disease, and there seems to be an opportunity for onco-cardiologists to fulfill this unmet need and help improve outcomes.